A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

NCT02261493 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

787

Enrollment

INDUSTRY

Sponsor class

Conditions

Facial Rhytides
Glabellar Rhytides

Interventions

BIOLOGICAL: OnabotulinumtoxinA
DRUG: Normal Saline

Sponsor

Allergan